Close this search box.

Why RNA Advisors?

Why RNA - Venn Diagram

When you retain RNA Advisors, you hire an experienced team of financial and strategic advisors focused, exclusively, on the Life Sciences and Healthcare sectors.

We are not generalists. When you retain RNA Advisors, you hire an experienced team of financial and strategic advisors focused, exclusively (and deliberately), on the Life Sciences and Healthcare sectors.

This narrow focus gives us unique insights into the industry subsectors and the ecosystem enabling both “the science” and innovation to flourish. Our diverse client base provides opportunities for us to cultivate a deep understanding of, and relationships with, industry players so that we can develop data-driven narratives of value that successfully meet the scrutiny of capital market and other stakeholders.

We work collaboratively with our clients to finetune their strategies, tell their valuation stories and improve their decision-making processes based on “the science”, market potential and financial forecasts. We do not believe in purely automated or algorithmic approaches to valuation. We do believe in carefully crafting the investor narratives, numbers and the deal psychology that drive compelling valuation perspectives and successful client outcomes.

Our portfolio of successful client engagements is testament to the RNA team's exceptional depth and breadth of experience:

Why RNA Icons - Advisors


RNA Advisors

Why RNA Icons - Clients


Why RNA Icons - Engagements


Why RNA Icons - Funding


raised in preferred funding
Why RNA Icons - Transaction


in transactional asset value

Why Hire Us?

We are experts in the Life Sciences and Healthcare sectors.

We therefore have a deep knowledge of the science and systems in these sectors, payor and reimbursement dynamics and model constructs, with support from a wide network of industry relationships. This depth of expertise gives us a unique insider’s perspective.

We know that valuations in Life Sciences and Healthcare are distinctly different.

There are fewer comparable benchmarks, so you must have a deep understanding of different biotech segments, reimbursement schemes, ever-changing market conditions, how markets transact, and how decisions really get made and deals really get done. This is not an area for valuation generalists.

Our clients tell us that they think of us as a “Service” – not a “Product”.

Many clients treat us as an integral part of their business development team. RNA’s suite of client solutions is unlike that offered by other advisors (e.g., valuation firms, accounting firms and investment banks) because we are “full service” and can therefore support our clients for their full “life cycle”. We provide tax/regulatory advisory services, valuation opinions, forecast development and assessment services, business development support services, financial reporting opinions, strategic market assessments, buy side/sell side due diligence services, and fairness opinions (among other services).

We believe that while numbers and narratives are key, understanding how things work in the real world matters just as much.

At RNA, we know a valuation team must be much more than an analytical powerhouse. The case supporting valuation is best built using a strategic perspective, market savvy and “in the trenches” real-world experience executing transactions. Our ability to bridge the gap between a traditional academic view and actual market conditions is one key to our client’s success.

Our unique blend of strategic and analytic skillsets, and our more wholistic perspective about how to drive more value out of each engagement for our clients, is our “secret sauce” at RNA Advisors.

We like to evaluate the likely impacts of going down different paths for different scenarios, and then explore them in a collaborative fashion with our clients. Our clients tell us they value our flexibility, quick response, simple language, clear narratives and down-to-earth approach.

What Our Clients Say

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.